U.S. market Closed. Opens in 1 hour 11 minutes

THRX | Theseus Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/A
Cost of Revenue438.00K2.00K2.00K2.00K
Gross Profit-438.00K-2.00K-2.00K-2.00K
Operating Expenses54.09M27.34M6.84M4.94M
Selling, General & Admin18.39M9.01M878.00K818.00K
Research & Development35.70M18.33M5.96M4.12M
Other Operating Expenses3.48M28.00K-5.16M-2.24M
Operating Income-54.09M-27.34M-6.84M-4.94M
Other Expenses / Income3.48M28.00K-5.16M-2.24M
Before Tax Income-50.61M-27.31M-12.00M-7.18M
Income Tax Expenses-3.53MN/AN/AN/A
Net Income-47.08M-27.31M-12.00M-7.18M
Interest Expenses-3.53MN/AN/AN/A
Basic Shares Outstanding38.49M9.63M25.37M11.92M
Diluted Shares Outstanding38.49M9.63M25.37M11.92M
EBITDA-54.09M-27.33M-6.83M-4.94M
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT-54.14M-27.31M-12.00M-7.18M
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙